Loading…

Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(138)

Departments of 1  Biopharmaceutical Sciences, 2  Bioengineering, and 3  Medicine, University of Illinois at Chicago, and 4  Chicago Veterans Afffairs Health Care System, West Side Division, Chicago, Illinois 60612 The purpose of this study was to elucidate the interactions between pituitary adenylat...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied physiology (1985) 2002-10, Vol.93 (4), p.1377-1383
Main Authors: Tsueshita, Takaya, Gandhi, Salil, Onyuksel, Hayat, Rubinstein, Israel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Departments of 1  Biopharmaceutical Sciences, 2  Bioengineering, and 3  Medicine, University of Illinois at Chicago, and 4  Chicago Veterans Afffairs Health Care System, West Side Division, Chicago, Illinois 60612 The purpose of this study was to elucidate the interactions between pituitary adenylate cyclase-activating peptide (PACAP)-(1 38) and phospholipids in vitro and to determine whether these phenomena modulate, in part, the vasorelaxant effects of the peptide in the intact peripheral microcirculation. We found that the critical micellar concentration of PACAP-(1 38) was 0.4-0.9 µM. PACAP-(1 38) significantly increased the surface tension of a dipalmitoylphosphatidylcholine monolayer and underwent conformational transition from predominantly random coil in saline to -helix in the presence of distearoyl-phosphatidylethanolamine-polyethylene glycol (molecular mass of 2,000 Da) sterically stabilized phospholipid micelles (SSM) ( P  
ISSN:8750-7587
1522-1601
DOI:10.1152/japplphysiol.00277.2002